Researchers have identified a factor that prevents SOD1 — a protein causing amyotrophic lateral sclerosis (ALS) in a proportion of patients —…
Articles by Magdalena Kegel
Oxford BioDynamics is expanding its program for biomarker discovery with tests for amyotrophic lateral sclerosis (ALS) in a clinical study…
Researchers at Case Western Reserve University School of Medicine have shed light on the mechanism by which a protein called TDP-43…
A molecular discovery explaining how motor neuron disease develops draws additional parallels between amyotrophic lateral sclerosis (ALS) and another neurodegenerative disease,…
Researchers at Torrey Pines Institute for Molecular Studies, in Florida, discovered that patients with amyotrophic lateral sclerosis (ALS) have lower…
Attempting to lower a specific protein that is higher in patients with amyotrophic lateral sclerosis (ALS), researchers discovered that the protein does not contribute to…
By screening nearly 250 factors in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS), Chinese researchers were able to…
Activity seen in two of the brain’s resting state networks in amyotrophic lateral sclerosis (ALS) patients may be a sign of…
Mutations in the SOD1 gene, a major copper-binding protein, are a known cause of familial amyotrophic lateral sclerosis (ALS). An extensive…
SOD1 protein aggregates can spread in a prion-like way, rapidly causing amyotrophic lateral sclerosis (ALS) when injected into the spinal…